Anthony Howell

Active 1984–2025

252
Papers
49,670
Citations
129
h-index
238
i10-index

Citations

Citations per year for Anthony Howell1959: 1 citations1984: 2 citations1985: 7 citations1986: 1 citations1987: 8 citations1988: 7 citations1989: 9 citations1990: 11 citations1991: 21 citations1992: 24 citations1993: 23 citations1994: 46 citations1995: 65 citations1996: 66 citations1997: 80 citations1998: 135 citations1999: 143 citations2000: 160 citations2001: 200 citations2002: 204 citations2003: 274 citations2004: 311 citations2005: 283 citations2006: 322 citations2007: 334 citations2008: 369 citations2009: 325 citations2010: 407 citations2011: 569 citations2012: 713 citations2013: 620 citations2014: 542 citations2015: 527 citations2016: 468 citations2017: 504 citations2018: 450 citations2019: 1,207 citations2020: 1,323 citations2021: 1,258 citations2022: 863 citations2023: 746 citations2024: 838 citations2025: 388 citations2026: 17 citations1960–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,370 citing papers, 26.7% of this breakdownUnited Kingdom: 1,732 citing papers, 10.6% of this breakdownChina: 1,186 citing papers, 7.2% of this breakdownItaly: 853 citing papers, 5.2% of this breakdownCanada: 705 citing papers, 4.3% of this breakdownGermany: 630 citing papers, 3.8% of this breakdownAustralia: 564 citing papers, 3.4% of this breakdownFrance: 491 citing papers, 3% of this breakdownNetherlands: 392 citing papers, 2.4% of this breakdownIndia: 364 citing papers, 2.2% of this breakdownSpain: 346 citing papers, 2.1% of this breakdownSwitzerland: 312 citing papers, 1.9% of this breakdown
0%26.7%Other 27.2%

Fields

  • Medicine48%
  • Biochemistry, Genetics and Molecular Biology44.2%
  • Immunology and Microbiology1.5%
  • Computer Science1.1%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Materials Science0.7%
  • Other3.7%

Topics

  • Breast Cancer Treatment Studies5.5%
  • Estrogen and related hormone effects5%
  • Cancer, Hypoxia, and Metabolism3.7%
  • BRCA gene mutations in cancer3.1%
  • Cancer Risks and Factors2.8%
  • Cancer Cells and Metastasis2.6%
  • Other77.3%

Coauthors

All papers

Open in search
  1. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women

    Authors: , , , , , , , , , , , , , , , - International Journal of Obesity 2010 cited by 813

  2. Ketones and lactate “fuel” tumor growth and metastasis

    Authors: , , , , , , , , , , , - Cell Cycle 2010 cited by 569

  3. Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

    Authors: , , , , , , - The Lancet Oncology 2014 cited by 460

  4. Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer

    Authors: , , , , , , , , , , , , - Cell Cycle 2011 cited by 341

  5. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production

    Authors: , , , , , , , , , , , - Cell Cycle 2012 cited by 308

  6. The effect of intermittent energy and carbohydrate restrictionv. daily energy restriction on weight loss and metabolic disease risk markers in overweight women

    Authors: , , , , , , , , , , , , , , , - British Journal Of Nutrition 2013 cited by 458

  7. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease

    Authors: , , , , , , , - Oncotarget 2015 cited by 469

  8. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial

    Authors: , , , , , , , , , - The Lancet 2019 cited by 231

  9. Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Marike Gabrielson, Manuela Gago-Domínguez, Jürgen Geisler, Graham G. Giles, Pascal Guénel, Andreas Hadjisavvas, Eric Hahnen, Per Hall, Ute Hamann, Jaana M. Hartikainen, Mikael Hartman, Reiner Hoppe, Anthony Howell, Anna Jakubowska, Audrey Jung, Э. К. Хуснутдинова, Vessela N. Kristensen, Jingmei Li, Swee Ho Lim, Annika Lindblom, Maria A. Loizidou, Artitaya Lophatananon, Jan Lubiński, Michael J. Madsen, Arto Mannermaa, Mehdi Manoochehri, Sara Margolin, Dimitrios Mavroudis, Roger L. Milne, Nur Aishah Mohd Taib, Anna Morra, Kenneth Muir, Nadia Obi, Ana Osório, Tjoung‐Won Park‐Simon, Paolo Peterlongo, Paolo Radice, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Xueling Sim, Melissa C. Southey, Heather Thorne, Ian Tomlinson, Diana Torres, Thérèse Truong, Cheng Har Yip, Amanda B. Spurdle, Maaike P.G. Vreeswijk, Alison M. Dunning, Montserrat García‐Closas, Paul D.P. Pharoah, Anders Kvist, Taru Muranen, Heli Nevanlinna, Soo‐Hwang Teo, Peter Devilee, Marjanka K. Schmidt, Douglas F. Easton - JAMA Oncology 2022 cited by 190

  10. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

    Authors: , , , , , , - The Lancet Oncology 2010 cited by 1,687

  11. Autophagy in cancer associated fibroblasts promotes tumor cell survival

    Authors: , , , , , , , , , , , , , , , , - Cell Cycle 2010 cited by 416

  12. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

    Authors: , , , , , , , , , , , , - The Lancet 2013 cited by 585

  13. Potential Benefits and Harms of Intermittent Energy Restriction and Intermittent Fasting Amongst Obese, Overweight and Normal Weight Subjects—A Narrative Review of Human and Animal Evidence

    Authors: , - Behavioral Sciences 2017 cited by 171

  14. Tamoxifen evolution

    Authors: , - British Journal of Cancer 2023 cited by 75

  15. Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 744

  16. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect

    Authors: , , , , , , , , , - Cell Cycle 2011 cited by 269

  17. Ketone body utilization drives tumor growth and metastasis

    Authors: , , , , , - Cell Cycle 2012 cited by 211

  18. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William M. Gallagher, Montserrat García‐Closas, Julia M.W. Gee, Andy J Gescher, Vicky Goh, Ashley M. Groves, Amanda Harvey, Michelle Harvie, Bryan T. Hennessy, Stephen Hiscox, Ingunn Holen, Sacha J. Howell, Anthony Howell, Gill Hubbard, Nick Hulbert-Williams, Myra S. Hunter, Bharat Jasani, J. Louise Jones, Timothy J. Key, Cliona Kirwan, Anthony Kong, Ian Kunkler, Simon P. Langdon, Martin O. Leach, David J. Mann, John F. Marshall, Lesley Martin, Stewart G. Martin, J Macdougall, David Miles, William R. Miller, Joanna R. Morris, Sue Moss, Paul B. Mullan, Rachael Natrajan, James P.B. O’Connor, Rosemary O’Connor, Carlo Palmieri, Paul D.P. Pharoah, Emad A. Rakha, Elizabeth Reed, Simon P. Robinson, Erik Sahai, John Saxton, Peter Schmid, Matthew J. Smalley, Valerie Speirs, Robert C. Stein, Julia Stingl, Charles Streuli, Andrew Tutt, Galina Velikova, Rosemary A. Walker, Christine J. Watson, Kaye J. Williams, Leonie S. Young, Alastair M. Thompson - Breast Cancer Research 2013 cited by 426

  19. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

    Authors: , , , , , , , , , - The Lancet 2005 cited by 2,281

  20. Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 729

  21. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ

    Authors: , , , , , , , , , , , , , - Cell Cycle 2011 cited by 299

  22. Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis

    Authors: , , , , , , , , , , - Antioxidants and Redox Signaling 2011 cited by 281

  23. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort

    Authors: , , , , , , , , , , , , , , , , , , , - Breast Cancer Research 2015 cited by 255

  24. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution

    Authors: , , , , , , , , , , , , , , , - Cell Cycle 2010 cited by 456